Severe i m p a i m n t of linear growth without evidence of endocrine dysfunction frequently complicates CD in childhood. The impact of nutritional intervention was studied in 7 patients(pts1 (5 boys,2 girls, ages 9-17 yrslwith CD and linear growth arrest for at least 1 yr prior to study. 6/7 were less than 3rdQ: height and bone ages ranged 5-11 and 6-13 yrs respectively. All were in clinical remission: 3 were maintained on a constant dose of steroid. Fasting somatomedin (3/3) and stimulated growth hormone levels (5/5) were normal. On metabolic balances prior to therapy, 5 pts demonstrated inadequate caloric intake(50520 kcal/kg;normal for height 75-85 kcal/kg); none had positive nitrogen balance; 1 had steatorrhea. Oral feeding was supplemented with intravenous hyperalimentation to total daily intake of 77+8 kcal/kg for 6-8 w k s During treatment, lean body m a s s (~~l 0 increased 2.2-7.3 kg in 5 pts mtudied. All pts exhibited weight gain(range 2.4-7.4 kg),linear growth (range 1.0-2.3cm1, and a significant increase in growth velocity (0.7+0.2cm/month.p<.001) . Linear grovth persisted following therapy and averaged 0.4+.jcm/month (pc.02) for '3-6 months. Subsequent growth in the 4 pts with long-term followup has totalled 2.5,9,10 and 20 cm respectively at 1.5-2.5 yr. The lowest growth increment occurred in the only pubertal pt. Conclusions: 1. Inadequate caloric intake explains the growth arrest in these children with CD# 2. caloric supplementation via intravenous hyperalimentation produces improvement in anthropometric values and a dramatic linear growth spurt that continues after therapy is terminated. + 4mgX (mean+_SEM.n-lo). In 3 infants, infused for 1--3 weeks the -increases in free cholesterol were 105, 115 and 117mgX. Cholesterol esters remained constant. The rise in free cholesterol occurred exclusively in the density range 1.006-1.063gIm. correaponding to low density Lipoproteins (LDL). Fractionation of this LDL on hydroxyapatite yielded 2 components, one corresponding to LP-X and the other an LDL-like particle with Apo B but increased cholesterol and phospholipid concentrations. LP-X, indistinguishable from that seen in cholestatic states, was confirmed by chromatographic and electrophoretic techniques; and on analysis contained free cholesterol (2673, phospholipid (65x1, albumin and Apo C proteins (6%).
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The etiology of the cholestasis andlor hepatocellular damage observed in some children on total parenteral nutritioh (TPN) remains undefined. Although amino acid imbalance in the infused solution has been implicated, we have not demonstrated any consistent correlation between serum amino acids and liver disease. However, because of the unresolved question of the role of bile acids in the pathogenesis of the condition. we studied bile acids in 8 premature infants on a Freamine 11-Intralipid-based solution and were able to separate them into two groups. Four developed hepatomegaly, marked elevations in serum enzymes (SGPT, LAP. GGT), and hyperbilirubinemia. Liver biopsies were obtained from 3 of the 4, and demonstrated canalicular cholestasis. The other 4 demonstrated less pronounced increases in serum enzymes and bilirubin, no clinically demonstrable hepatomegaly, and were not biopaied. Quantitative serum bile acids determined by TLC in the two groups demonstrgted a 50% increase in serum levels of unconjugated, secondary bile acids (CDC, DOC, LiC) in the more severely affected group. Although this proves no cause-effect relationship between TPN-associated liver disease and serum bile acids, it documents a distinct difference in the serum bile acid concentrations of those infants with frank liver disease and others with only biochemical changes. + 4mgX (mean+_SEM.n-lo). In 3 infants, infused for 1--3 weeks the -increases in free cholesterol were 105, 115 and 117mgX. Cholesterol esters remained constant. The rise in free cholesterol occurred exclusively in the density range 1.006-1.063gIm. correaponding to low density Lipoproteins (LDL). Fractionation of this LDL on hydroxyapatite yielded 2 components, one corresponding to LP-X and the other an LDL-like particle with Apo B but increased cholesterol and phospholipid concentrations. LP-X, indistinguishable from that seen in cholestatic states, was confirmed by chromatographic and electrophoretic techniques; and on analysis contained free cholesterol (2673, phospholipid (65x1, albumin and Apo C proteins (6%).
HYPERCHOLESTEROLEMIA AND LIPOPROTEIN-X(LP-
Using agar electrophoresis LP-X appeared in the plasma within 8hrs of starting the Intralipid infusion and disappeared within 48hrs of stopping. LP-X appeared despite close monitoring of plasma Intralipid levels which were maintained at lOOmgX or less. Because LP-X is associated with excessive tissue cholesterol accumulation, this Intralipid induced dysliproproteinemia cannot be viewed as a trivial metabolic complication. One of the six neonates receivir-. low done EFA-rich oil had mild EFA deficiency (trienoicltetraenoic ratio, or TIT, .93) which was reverned with the topical oil (TIT .37); the other five low dose patients had si~nificant worsening of their EFA deficiency ( m a n TIT 1.4 and, later, 13.6).
3 6 FACTORS A F F E C T~G LOWER ESOPHAGEAL SPHINCTER CCW
All four patient6 receiving long term PN developed s w e r e deficiency (mean TIT 11.2) desptte high dose topical EFA-rich oil; one of these four also developed a severe dermatitis recondary to EFA deficiency. In any patient, the topical applicatio~ of an EFA-rich oil cannot be assumed to be effective in reversing or preventing FFA deficiency unlesm documented by aoproprtnte blood and tissue EPA masrrrements.
